Oncology

Latest News

Value-Based Care Veterans, Surprised by EOM Results, Ponder Next Move
Value-Based Care Veterans, Surprised by EOM Results, Ponder Next Move

September 11th 2025

Community oncology leaders navigate challenges in value-based care under the Enhancing Oncology Model, facing performance payment uncertainties and evolving drug markets.

FDA | Image credit: Postmodern Studio.jpeg
FDA Approves Selumetinib for Children With NF1 and Inoperable Tumors

September 10th 2025

Current and Emerging Options for Uncommon EGFR- and Exon 20 Insertion–Mutated NSCLC
Current and Emerging Options for Uncommon EGFR- and Exon 20 Insertion–Mutated NSCLC

September 8th 2025

Clinical Advances in EGFR-Mutated NSCLC: Insights From MARIPOSA and FLAURA2
Clinical Advances in EGFR-Mutated NSCLC: Insights From MARIPOSA and FLAURA2

September 7th 2025

Evolving Roles of Antibody-Drug Conjugates in the Treatment of NSCLC
Evolving Roles of Antibody-Drug Conjugates in the Treatment of NSCLC

September 7th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo